Skip to content

Continuous Glucose Monitoring in New Mothers With Type 1 Diabetes

Continuous Glucose Monitoring During Breastfeeding or Formula Feeding in New Mothers With Type 1 Diabetes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02898428
Enrollment
65
Registered
2016-09-13
Start date
2016-04-30
Completion date
2018-04-30
Last updated
2018-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breastfeeding, Hypoglycemia

Brief summary

With appropriate day-time carbohydrate intake and insulin dose, the 24 hour glucose levels and prevalence of night-time hypoglycaemia are comparable in breastfeeding new mothers and formula feeding new mothers with type 1 diabetes at the second after delivery diabetes control compared with the first after delivery diabetes control at Steno Diabetes Center.

Interventions

DEVICEContinuous glucose monitoring (CGM)

Sponsors

Steno Diabetes Center Copenhagen
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 45 years. * Delivery of a single infant. * Proficiency in Danish to read and understand the patient information sheet, questionnaires and to converse with the diabetes caregivers.

Exclusion criteria

* A diagnosis with severe mental or psychiatric barriers or a concurrent disease on the decision of the principal investigator

Design outcomes

Primary

MeasureTime frame
HypoglycemiaNight-time 8 hours

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026